Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1995-2-8
pubmed:abstractText
The role of endothelium in angiotensin II-induced contractions of the rabbit aorta and the mechanism involved were investigated. Destruction of the endothelium significantly shifted the concentration-response curve for angiotensin II to the left in a non-parallel manner and enhanced the maximal response. The EC50 and Emax values obtained from the rings with and without functional endothelium were 2.44 +/- 0.13 x 10(-9) M, 4.50 +/- 0.45 g and 1.21 +/- 0.14 x 10(-9) M (n = 8, P < 0.05), 5.73 +/- 0.55 g (n = 8, P < 0.05), respectively. Indomethacin (10(-5) M) did not significantly alter the concentration-dependent response to angiotensin II in the presence of endothelium. Three inhibitors of nitric oxide synthase (NG-monomethyl-L-arginine; NG-nitro-L-arginine, and NG-nitro-L-arginine methyl ester) at 10(-4) M caused a similar endothelium-dependent potentiation of angiotensin II-induced contractions in the aortic rings with, but not in those without endothelium. These effects were reversed by L-arginine (3 x 10(-3) M) but not by D-arginine (3 x 10(-3) M). Angiotensin II in a concentration range of 10(-16) to 10(-6) M did not relax the endothelium-intact rings precontracted with phenylephrine (2 x 10(-7) M). In the presence of endothelium, the angiotensin II subtype 2 receptor antagonist, 1-[(4-amino-3-methylphenyl]-5-(diphenylacetyl)-4,5,6,7-tetrahydro- 1H- imidazol[4,5-C]pyridine-6-carboxylic acid (PD 123177), caused neither relaxation of the rings precontracted with phenylephrine nor alteration of the concentration-response curve for angiotensin II.(ABSTRACT TRUNCATED AT 250 WORDS)
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Acetylcholine, http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin II, http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin Receptor Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Arginine, http://linkedlifedata.com/resource/pubmed/chemical/Imidazoles, http://linkedlifedata.com/resource/pubmed/chemical/Indomethacin, http://linkedlifedata.com/resource/pubmed/chemical/NG-Nitroarginine Methyl Ester, http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide, http://linkedlifedata.com/resource/pubmed/chemical/Nitroarginine, http://linkedlifedata.com/resource/pubmed/chemical/PD 123177, http://linkedlifedata.com/resource/pubmed/chemical/Pyridines, http://linkedlifedata.com/resource/pubmed/chemical/omega-N-Methylarginine
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0014-2999
pubmed:author
pubmed:issnType
Print
pubmed:day
12
pubmed:volume
262
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
247-53
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:7813589-Acetylcholine, pubmed-meshheading:7813589-Angiotensin II, pubmed-meshheading:7813589-Angiotensin Receptor Antagonists, pubmed-meshheading:7813589-Animals, pubmed-meshheading:7813589-Aorta, pubmed-meshheading:7813589-Arginine, pubmed-meshheading:7813589-Dose-Response Relationship, Drug, pubmed-meshheading:7813589-Endothelium, Vascular, pubmed-meshheading:7813589-Imidazoles, pubmed-meshheading:7813589-Indomethacin, pubmed-meshheading:7813589-Male, pubmed-meshheading:7813589-Muscle, Smooth, Vascular, pubmed-meshheading:7813589-Muscle Contraction, pubmed-meshheading:7813589-Muscle Relaxation, pubmed-meshheading:7813589-NG-Nitroarginine Methyl Ester, pubmed-meshheading:7813589-Nitric Oxide, pubmed-meshheading:7813589-Nitroarginine, pubmed-meshheading:7813589-Pyridines, pubmed-meshheading:7813589-Rabbits, pubmed-meshheading:7813589-omega-N-Methylarginine
pubmed:year
1994
pubmed:articleTitle
Endothelium-dependent, nitric oxide-mediated inhibition of angiotensin II-induced contractions in rabbit aorta.
pubmed:affiliation
Department of Pharmacotherapy, University of Amsterdam, Netherlands.
pubmed:publicationType
Journal Article, In Vitro